Squalene attenuates doxorubicin resistance in hepatocellular carcinoma by targeting SIRT6 to inhibit ERK1 deacetylation.
Saved in:
| Title: | Squalene attenuates doxorubicin resistance in hepatocellular carcinoma by targeting SIRT6 to inhibit ERK1 deacetylation. |
|---|---|
| Authors: | Xiao G; Department of Oncology, Affiliated Hospital of Shaoxing University, Shaoxing, China., Liu F; Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shaoxing, China., Wang Q; Department of Oncology, Affiliated Hospital of Shaoxing University, Shaoxing, China., He B; Department of Radiology, Affiliated Hospital of Shaoxing University, Shaoxing, China. 13857566560@163.com., Fu Y; Department of Oncology, Affiliated Hospital of Shaoxing University, Shaoxing, China. fym764155283@163.com. |
| Source: | Molecular and cellular biochemistry [Mol Cell Biochem] 2026 Jun; Vol. 481 (6), pp. 2593-2606. Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
